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In the early embryonic cell cycle, exit from M phase is immediately followed by entry into S phase without an intervening
gap phase. To understand the regulatory mechanisms for the cell cycle transition from M to S phase, we examined
dependence on Cdc2 inactivation of cell-cycle events occurring during the M-S transition period, using Xenopus egg extracts
in which the extent of Cdc2 inactivation at M phase exit was quantitatively controlled. The result demonstrated that MCM
binding to and the initiation of DNA replication of nuclear chromatin occurred depending on the decrease of Cdc2 activity
to critical levels. Similarly, we found that Cdc2 inhibitory phosphorylation and cyclin B degradation were turned on and off,
respectively, depending on the decrease in Cdc2 activity. However, their sensitivity to Cdc2 activity was different, with the
turning-on of Cdc2 inhibitory phosphorylation occurring at higher Cdc2 activity levels than the turning-off of cyclin B
degradation. This means that, when cyclin B degradation ceases at M phase exit, Cdc2 inhibitory phosphorylation is
necessarily activated. In the presence of constitutive synthesis of cyclin B, this condition favors the occurrence of the Cdc2
inactivation period after M phase exit, thereby ensuring progression through S phase. Thus, M phase exit and S phase entry
are coordinately regulated by the Cdc2 activity level in the early embryonic cell cycle. © 2002 Elsevier Science (USA)
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The mitotic cycle of early embryonic cells differs from
that of other somatic cells. The standard somatic cell cycle
consists of M phase and S phase with the two intervening
gap periods, G1 and G2 phases, during which neither
mitosis nor DNA replication takes place. In contrast, the
early embryonic cell cycle consists of rapidly alternating M
phase and S phase without distinguishable G phases (Gra-
ham, 1966) except that G2 phase is present in the first
mitotic cycle of Xenopus embryos, owing to a specific
regulation (Gerhart et al., 1984; Murakami et al., 1999).
Thus, in the early embryonic cell cycle, exit from M phase
appears to be temporally linked with entry into S phase,
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34suggesting that the two cell cycle events may be coordi-
nated.
In any eukaryotic cell, exit from M phase is induced by
inactivation of cyclin B-Cdc2 kinase. Inactivation of Cdc2
at M phase exit is caused by proteolysis of cyclin B that is
dependent on APC/cyclosome (Townsley and Ruderman,
1998). In standard somatic cells, Cdc2 activity is absent
during G1 and S phases, since the APC-dependent proteol-
ysis of cyclin B remains active during G1 phase (Townsley
and Ruderman, 1998). In addition, de novo synthesis of
cyclin B required for Cdc2 activation commences in G2
phase, being controlled by cell cycle-specific transcription
and translation (Brandeis and Hunt, 1996). In contrast, in
early embryonic cells, cyclin B is constitutively synthesized
and starts accumulating shortly after exit from M phase
(Evans et al., 1983; Murray and Kirschner, 1989). However,
Cdc2 activation is restrained for a while, during which time
S phase is completed, by inhibitory phosphorylation of
threonine-14 and tyrosine-15 of Cdc2 (Coleman and Dun-
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phy, 1994; Morgan, 1995). The occurrence of Cdc2 inhibi-
tory phosphorylation at the onset of S phase, which is
catalyzed by Wee1 and Myt1 (Mueller et al., 1995a,b), is
thought to be required for successful transition from M
phase to S phase in the early embryonic cell cycle, since the
absence of Cdc2 inhibitory phosphorylation at M phase exit
is closely related to the subsequent transition to M phase in
the meiotic cell cycle during oocyte maturation (Nakajo et
al., 2000; Iwabuchi et al., 2000; Tachibana et al., 2000).
Recent studies on the regulation of S phase have revealed
that a two-step process is required for entry into S phase
(Diffley, 1996). In the first step, which is completed during
G1 phase, prereplicative complexes (pre-RCs) are formed on
nuclear chromatin by sequential binding of ORC, Cdc6, and
MCM (Diffley and Cocker, 1992; Diffley et al., 1994;
Aparicio et al., 1997; Donovan et al., 1997; Tanaka et al.,
1997). In the second step, certain cyclin-dependent kinases
(CDKs) and Cdc7-Dbf4 kinase are activated, depending on
G1-phase-specific transcription and translation, by which
DNA replication is initiated (Stillman, 1996). In yeast,
MCM proteins are shown to be physiological substrates of
Cdc7-Dbf4 (Lei et al., 1997), and the activation of CDKs
promotes Cdc45 loading onto replication origins, by which
replication is initiated (Zou and Stillman, 1998). Interest-
ingly, in the early embryonic cell cycle, where G1 phase is
thought to be absent, pre-RCs are formed on nuclear chro-
matin during a very short period between metaphase–
anaphase transition and the onset of S phase (Jares and
Blow, 2000). However, regulatory mechanisms for arranging
these steps in proper sequential order during the M-S
transition period have not been elucidated.
In this study, we have investigated the regulatory mecha-
nisms for the cell cycle transition from M phase to S phase
without distinguishable G1 phase in the early embryonic
cell cycle. Considering that M phase is dominant over the
other cell cycle phases (Johnson and Rao, 1970), it seems
plausible that Cdc2 inactivation at M phase exit is also
involved in the regulation of S phase entry in the early
embryonic cell cycle. We therefore examined the depen-
dence on the Cdc2 activity level of cell cycle events taking
place during the M-S transition period, using cell-free
extracts from Xenopus eggs in which the extent of Cdc2
inactivation at M phase exit is quantitatively controlled.
The results showed that all the cell cycle events examined,
which relate to M phase exit and S phase entry, are strictly
dependent on, but differentially sensitive to, the decrease in
Cdc2 activity at M phase exit, suggesting that M phase exit
and S phase entry are coordinately regulated by the Cdc2
activity level in the early embryonic cell cycle.
MATERIALS AND METHODS
cyclin B-Dependent Extracts
CSF extracts from unfertilized Xenopus eggs were prepared by
the method of Murray (1991). The N-terminal region encoding
amino acids 1-105 was deleted from a full-length Xenopus cyclin B1
cDNA (gift from Dr. T. Hunt), and the deleted version was fused to
the glutathion S-transferase (GST) gene. Both GST-N85cyclin B2
(N-cyclin B2; Iwabuchi et al., 2000) and GST-N105cyclin B1
(N-cyclin B1) proteins were expressed in Escherichia coli BL21
and purified according to the manufacturer’s protocol (Amersham
Pharmacia Biotech). CSF extracts were added with N-cyclin B to
a final concentration of 250 nM, incubated for 30 min at 22°C, then
activated by the addition of CaCl2 to a final concentration of 0.4
M. Activated CSF extracts that had been preincubated with
N-cyclin B were treated with 50 g/ml cycloheximide (CHX),
then serially diluted with activated and CHX-treated CSF extracts
free of N-cyclin B.
Detection of XMcm3 and DNA Replication
XMcm3 binding to and DNA replication of sperm chromatin
were detected by the method of Madine et al. (1995) with modifi-
FIG. 1. The dependence on the Cdc2 activity level of cell-cycle
phase reflected by sperm chromatin morphology in cyclin
B-dependent extracts from Xenopus eggs. (A) CSF extracts that had
been treated with cycloheximide and various amounts of indestruc-
tible cyclin B (N-cyclin B2) were added with calcium to induce
degradation of endogenous M phase cyclins and resulting Cdc2
inactivation at M phase exit, and immunoblotted with specific
antibodies after a 30-min incubation. An asterisk indicates the
active form of Cdc2. (B) Cdc2 activity in cyclin B-dependent
extracts was measured 30 min after calcium addition, using histone
H1 as a substrate. Cdc2 activity levels in extracts are represented as
relative values to that in the same batch of extract devoid of M
phase cyclins. Open, shaded, and solid symbols represent extracts
where sperm chromatin was transformed into condensed chromo-
somes, telophase-like chromatin masses, and nuclei, respectively.
(C) Demembranated sperm were added to cyclin B-dependent
extracts at the time of calcium addition and stained with Hoechst
33342 at 30 (a) and 60 min (b) after incubation. Numbers in each
panel indicate the relative Cdc2 activity of the extracts. Scale bar
indicates 10 m.
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cations. Demembranated sperm were prepared as described previ-
ously (Ohsumi et al., 1993). Egg extracts were added with demem-
branated sperm (500 sperm/l) along with biotin-labeled
deoxyuridine triphosphate (dUTP) (Boehringer Mannheim) to a
final concentration of 20 M and incubated for 75 min at 22°C.
Twenty microliters of extracts were fixed by mixing with 4%
FIG. 2. XMcm3 binding to and DNA replication of sperm chromatin in cyclin B-dependent extracts. CSF extracts that had been treated
with cycloheximide and various amounts of indestructible cyclin B (N-cyclin B2) were added with demembranated sperm along with
biotin-labeled dUTP. Sperm were fixed and sedimented onto a coverslip at 70 min after calcium addition and examined for XMcm3 binding
and DNA replication by staining with anti-XMcm3 antibody and streptavidin–Texas Red, respectively. DNA was stained with Hoechst
33342. The nuclear accumulation of fluorescence-labeled nucleoplasmin (Npl) and the morphology of sperm chromatin before fixation are
indicated at the right of the figures: M, condensed chromosome T, telophase-like chromatin masses; S, nuclei. Numbers in panels indicate
the relative Cdc2 activity of the extracts. Scale bar indicates 10 m.
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formaldehyde in PBS, and sperm chromatin was spun onto
polylysine-coated coverslips through 30% sucrose in PBS. After
treatment with blocking solution (0.1% Triton X-100, 0.02% SDS,
2% skimmed milk), coverslips were incubated with an anti-
Xenopus Mcm3 antibody (gift from Dr. H. Takisawa) for 1 h at
37°C, then stained with blocking solution containing Texas Red–
streptavidin (Amersham Pharmacia Biotech) and fluorescein-
conjugated anti-rabbit IgG (Cappel Labs) for 1 h at 37°C. After being
counterstained with Hoechst 33342, coverslips were mounted onto
glass slides with 50% glycerol in PBS and observed under an
epifluorescence microscope (Zeiss Axiophoto).
Kinase Assays
The kinase activity of Cdc2 and immunoprecipitated Wee1 was
measured as described previously (Iwabuchi et al., 2000). For Cdc2
activity assay, extracts were quickly frozen in liquid nitrogen and
stored at 80°C. Frozen extracts were thawed by adding 9 volumes
of ice-cold H1 kinase buffer (80 mM -glycerophosphate, 20 mM
EGTA, 5 mM MgCl2, 20 mM Hepes–KOH, pH 7.5). Ten microliters
of diluted extracts were mixed with 20 l of reaction buffer (80 mM
-glycerophosphate, pH 7.4, 20 mM MgCl2, 0.6 mM ATP, 30 g/ml
leupeptin, 30 g/ml aprotinin, 0.6 mg/ml histone H1, and 1 Ci
[-32P]ATP), and incubated for 30 min at 25°C. Reactions were
stopped by the addition of SDS-sample buffer and boiling for 2 min.
Histone H1 was separated by SDS-PAGE and stained with Coomas-
sie blue, and the band was excised. 32P incorporation into the gel
slice was quantitated by the Cerenkov method.
For Wee1 activity assay, 10 l of extract was added with an
anti-Xenopus Wee1 serum and incubated on ice for 1 h. After
dilution of extracts with IP buffer (80 mM -glycerophosphate, 20
mM EGTA, 5 mM MgCl2, 0.1 mM dithiothreitol, 0.1% Nonidet
P-40, 10 g/ml leupeptin, 10 g/ml aprotinin, 20 mM Hepes–KOH,
pH 7.5) containing 0.5 M okadaic acid, immunocomplexes were
isolated with protein A-Sepharose CL-4B (Amersham Pharmacia
Biotech), washed once with buffer A (IP buffer containing 1 M
okadaic acid, 25 mM NaF, and 1 mM Na3VO4), twice with buffer B
(buffer A minus okadaic acid), twice with buffer C (buffer B minus
Nonidet P-40), and finally, twice with kinase buffer (10 mM MgCl2,
1 mM dithiothreitol, 50 mM Tris–HCl, pH 7.5), and immediately
used for kinase assay. The beads were incubated for 10 min at 18°C
with kinase-negative (KN)-Cdc2-cyclin B in the presence of
[-32P]ATP (200 Ci/ml) and 5 M ATP in kinase buffer. Reactions
were stopped by the addition of SDS-sample buffer and boiling for
2 min. KN-Cdc2 was separated by SDS-PAGE, and its 32P-
incorporation was measured by Imaging Analyzer Fujix BAS2000
(Fuji Film).
Cyclin B Degradation Assay
[35S]Methionine-labeled cyclin B was prepared with egg extracts
according to the method of Murray and Kirschner (1989) and
Mahaffey et al. (1995) with modifications. A full-length cyclin B2
mRNA was transcribed and capped in vitro by using an mCAPTM
mRNA Capping Kit (Stratagene). Activated CSF extracts in inter-
phase were added with RNase A (0.25 g/ml final; Nacarai Tesque,
Japan) and incubated for 20 min at 10°C, then added with dithio-
threitol (3 mM final), RNasin (0.5 unit/l final; Boehringer Mann-
heim), and RNase inhibitor (0.5 unit/l final, Promega), and incu-
bated for 10 min at 10°C. One hundred microliters of the mixture
were added with tRNA (0.2 mg/ml final, Type X-SA; Sigma) and
[35S]methionine (1.0 mCi/ml final), and incubated for 3 min, then
added with cyclin B2 mRNA to a final concentration of 0.25 mg/ml
and incubated for 90 min at 22°C. The labeled product was
immediately frozen in liquid nitrogen and stored at 80°C.
For degradation assay, extracts to be assayed and the preparation
containing 35S-labeled cyclins were mixed at 19:1 (under these
conditions, the amount of labeled cyclin B was less than 3% of that
of endogenous cyclin B in CSF extract arrested in metaphase). After
a 10-min incubation, 35S-cyclin B was resolved by SDS-PAGE and
quantitated by using Fujix BAS2000. The relative destruction
activity was calculated from the amount of residual 35S-cyclin B,
taking the amount present in the extract without any M-phase
cyclins as 0% and none of it as 100%.
Immunological Methods
For immunoprecipitation of GST-N-cyclin B2, extract was
diluted with 3 volumes of EB (100 mM KCl, 5 mM MgCl2, 20 mM
Hepes–KOH, pH 7.5) containing an anti-cyclin B2 antibody (gift
from Dr. J. L. Maller), and incubated on ice for 2 h. After being
diluted further with 3 volumes of EB, the mixture was added with
protein G-Sepharose beads (Sigma) and incubated on a rotator for
1 h at 4°C. Protein G-Sepharose beads were washed once in low-salt
buffer (100 mM NaCl, 5 mM EDTA, 1% Triton X-100, 20 mM
Tris–HCl, pH 7.4) and twice in high-salt buffer (1 M NaCl, 5 mM
EDTA, 1% Triton X-100, 20 mM Tris–HCl, pH 7.4), then added
with SDS-sample buffer and boiled for 2 min.
For immunoblotting, extract was mixed with SDS-sample buffer,
boiled for 2 min, and run on 10 or 12.5% SDS-polyacrylamide gels.
Immunoblotting was performed as described previously (Iwabuchi
et al., 2000). Antibodies used were anti-Xenopus cyclin B1 and B2
(gift from Drs. J. L. Maller and T. Hunt), anti-PSTAIR (gift from Drs.
M. Yamashita and Y. Nagahama), anti-phosphotyrosine (gift from
Dr. G. Peaucellier), and anti-XWee1 (Iwabuchi et al., 2000). An
anti-Xenopus Myt1 antibody was raised in rabbits as follows. A
full-length XMyt1 cDNA (Mueller et al., 1995b) was isolated by
PCR, and the C-terminal region encoding 108 amino acids was
cloned into pTrcHis plasmid vector (Invitrogen). His-XMyt1C108
protein was expressed in E. coli BL21, purified with His-bind Resin
(Novagen), and used for immunization of rabbits. An anti-XMyt1
antibody was affinity-purified from antisera by using GST-
XMyt1C108 protein conjugated to Sepharose 4B (Amersham Phar-
macia Biotech). An anti-XCdc25 antibody was raised in rabbits
against 13 amino acids of the C-terminus of XCdc25 (Kumagai and
Dunphy, 1992). The C-terminus peptides conjugated to KLH
(PIERCE) were used for immunization of rabbits. The anti-peptide
antibody was affinity-purified from antisera, using nitrocellulose
strips onto which a histidine-tagged fusion protein containing the
C-terminus of XCdc25 was transferred.
RESULTS
Chromatin Morphology Is Determined by the Cdc2
Activity Level in Egg Extracts
To analyze the dependence of cell cycle events on Cdc2
inactivation at M phase exit, we used cell-free egg extracts
in which the decrease in Cdc2 activity at M phase exit
could be controlled to arrest at various levels. CSF extracts
from Xenopus unfertilized eggs are arrested at meiotic
metaphase II (Murray et al., 1989). After being treated with
various amounts of indestructible Xenopus cyclin B2 (N-
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cyclin B2), CSF extracts were added with CaCl2 to activate
degradation of endogenous M phase cyclins and treated
with cycloheximide to prevent de novo synthesis of cyclins.
Within 30 min after activation, endogenous M phase cyc-
lins of extracts were completely degraded, but exogenously
added N-cyclin B2 remained (Fig. 1A); N-cyclin B2 was
confirmed to be stable in activated CSF extracts during the
incubation period for at least 3 h (data not shown). In the
extracts, both the amount of the active form of Cdc2 and
the level of Cdc2 activity measured at 30 min after activa-
tion using histone H1 as a substrate were almost propor-
tional to the amount of exogenously added N-cyclin B2
(Figs. 1A and 1B), indicating that Cdc2 activity in the
extracts was sustained by the N-cyclin B2. Essentially the
same result was obtained by using Xenopus N-cyclin B1 in
place of N-cyclin B2 (data not shown). We refer to these
extracts as cyclin B-dependent extracts. For direct com-
parisons between separate experiments, Cdc2 activity lev-
els in cyclin B-dependent extracts were represented as
relative values to the histone H1 kinase activity of acti-
vated CSF extracts which had not been treated with any
cyclin B, since the histone H1 kinase activity of the
control extracts devoid of M phase cyclins did not vary from
extract to extract (data not shown). The level of Cdc2
activity in CSF extracts arrested at metaphase ranged from
8 to 12, variable depending on extracts, and these levels of
Cdc2 activity were generated by approximately 100 nM
N-cyclin B2 under our experimental conditions (Fig. 1B).
When added to cyclin B-dependent extracts at the time
of activation, demembranated sperm heads were trans-
formed into condensed chromosomes, telophase-like chro-
matin masses, or nuclei within 30 min of incubation,
depending on the amount of exogenously added cyclin B,
and hence the level of Cdc2 activity in the extracts (Figs. 1B
and 1C). In the next 15 min of incubation, telophase-like
chromatin masses formed nuclei, whereas condensed chro-
mosomes and nuclei were as they had been, suggesting that
the telophase-like state was unstable and transient. These
results strongly suggest that, in egg extracts, the cell cycle
phase reflected by chromatin morphology is determined
according to the Cdc2 activity level and the decrease of
Cdc2 activity to a critical level is required for exit from M
phase. It should be noted that the sequential change of
chromatin morphology along the decrease in the Cdc2
activity level in cyclin B-dependent extracts (Fig. 1C)
showed a good agreement with that along the time after
activation in CSF extracts (data not shown).
Differential Regulation of Pre-RC Formation and
DNA Replication by the Cdc2 Activity Level
In CSF extracts, pre-RC formation has been shown to
occur through sequential binding of ORC, Cdc6, and MCM
on chromatin within 10 min after metaphase–anaphase
transition (Jares and Blow, 2000). We examined the occur-
rence of XMcm3 binding, the last step of pre-RC formation,
on sperm chromatin in cyclin B-dependent extracts at 75
min after activation. The result showed that, in cyclin
B-dependent extracts treated with 70 nM N-cyclin B2,
XMcm3 bound to sperm chromatin, whereas it did not in
those treated with 75 nMN-cyclin B2 (Fig. 2), suggesting
that XMcm3 binding to chromatin was dependent on Cdc2
inactivation. XMcm3 binding was, however, independent of
chromatin decondensation at the end of M phase, as seen in
that XMcm3 bound not only to decondensed chromatin in
nuclei, but to telophase-like chromatin masses (65 nM
cycB) and entangled condensed chromosomes (70 nM
FIG. 3. The dependence of Cdc2 inhibitory phosphorylation on
the Cdc2 activity level. (A, B) Cdc2 activity in cyclin B-dependent
extracts was measured by using histone H1 as a substrate at 60 min
after activation by calcium addition (A). The cyclin B-dependent
extracts in M and S phase at 60 min after activation (M and S in A)
were further added with various amounts of N-cyclin B2, and
Cdc2 activity in the extracts was measured after a 30-min incuba-
tion period (B). Open and solid symbols represent extracts where
sperm chromatin was transformed into condensed chromosomes
and nuclei, respectively. Cdc2 activity levels of extracts are repre-
sented as relative values to that in the same batch of extract devoid
of M phase cyclins. (C) Cdc2 complexed to N-cyclin B2 was
isolated from the M- and S-phase extracts indicated in (A), and
immunoblotted with antibodies for PSTAIR (upper panel) and pY15
of Cdc2 (lower panel). (D) N-cyclin B-dependent extracts at 60
min after activation were immunoblotted with antibodies against
XWee1 (upper panel), XMyt1 (middle panel), and XCdc25C (lower
panel). (E) Complexes of KN-Cdc2 and N-cyclin B2 were incu-
bated in the presence of [-32P]ATP with XWee1 immunoprecipi-
tated from cyclin B-dependent extracts at 60 min after activation,
and processed for autoradiography.
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cycB) (Fig. 2; see also Fig. 1C for chromatin morphology
before fixation for immunostaining).
It has been extensively demonstrated that nuclear forma-
tion is required for the initiation of DNA replication in egg
extracts (Lohka and Masui, 1984; Newport, 1987; Blow and
Laskey, 1988). We examined the relationship between
nuclear formation and DNA replication in cyclin
B-dependent extracts. In agreement with the previous stud-
ies, DNA replication of sperm chromatin took place exclu-
sively in extracts where nuclei were formed; nuclear forma-
tion in the extracts was confirmed by accumulation of
fluorescence-labeled nucleoplasmin (Fig. 2). This result
strongly suggests that, in egg extracts, the initiation of
DNA replication is regulated, via nuclear formation, de-
pending on the Cdc2 activity level. Importantly, XMcm3
binding and nuclear formation accompanying DNA repli-
cation were differentially sensitive to Cdc2 activity, with
the former occurring at higher levels of Cdc2 activity than
the latter. This condition favors that pre-RC formation
precedes nuclear formation on the decline in Cdc2 activity
during the M-S transition period.
Dependence of Cdc2 Inhibitory Phosphorylation
on the Cdc2 Activity Level
Whether Cdc2 inhibitory phosphorylation occurs or not
at M phase exit is crucial for determining the following cell
cycle phase in oocyte extracts (Iwabuchi et al., 2000). Using
cyclin B-dependent extracts, we examined the dependence
of Cdc2 inhibitory phosphorylation on the Cdc2 activity
level. When we measured Cdc2 activity in cyclin
B-dependent extracts at 30 min after activation, its levels
were proportional to the amounts of exogenously added
cyclin B (Fig. 1B). However, in the next 30 min, only
background levels of Cdc2 activity were detected in ex-
tracts receiving N-cyclin B2 at the concentrations of 63
nM, whereas in those receiving greater amounts of N-
cyclin B2, Cdc2 activity in direct proportion to the N-
cyclin B2 amount was detected (Fig. 3A). To know the
reason for the decline of Cdc2 activity in the extracts
receiving the subthreshold amounts of N-cyclin B2, we
isolated N-cyclin B2 from these extracts with anti-cyclin
B2 antibody and examined the state of Cdc2 that coprecipi-
tated with the cyclin. The result revealed that the absence
of Cdc2 activity in the extracts was due to inhibitory
phosphorylation of Cdc2, but not to degradation of added
N-cyclin B2 or a failure of N-cyclin B2 to complex with
Cdc2 (Fig. 3C).
We also examined the state of Wee1, Myt1, and Cdc25C
in cyclin B-dependent extracts by immunoblotting. In
accordance with the occurrence of Cdc2 inhibitory phos-
phorylation, Wee1 and Myt1 were in the dephosphorylated,
active forms (Mueller et al., 1995a,b) and Cdc25C was in
the dephosphorylated, inactive form (Kumagai and Dunphy,
1992; Izumi and Maller, 1992) in extracts receiving the
subthreshold amounts of N-cyclin B2, whereas in those
receiving greater amounts of N-cyclin B2, Wee1 and Myt1
were in the inactive forms and Cdc25C was in the active
form (Fig. 3D). Consistent with this result, the kinase
activity of Wee1 measured using kinase-negative Cdc2 in
complex with N-cyclin B2 as a substrate was regulated in
an all-or-none fashion in cyclin B-dependent extracts,
depending on the amount of N-cyclin B2 added (Fig. 3E).
These results together indicate that Cdc2 inhibitory phos-
phorylation is turned on at the subthreshold levels of Cdc2
activity in egg extracts. The relative level of Cdc2 activity
for Cdc2 inhibitory phosphorylation to be activated is
estimated to be 3.5–4.0 from the concentration of N-
cyclin B2 required for keeping Cdc2 from its inactivation by
inhibitory phosphorylation.
Under the constitutive synthesis of cyclin B, the occur-
rence of Cdc2 inhibitory phosphorylation at M phase exit is
thought to be required for suppressing precocious activation
of Cdc2, which can cause the abortion of S phase. To
examine this, we added various amounts of N-cyclin B2
again to cyclin B-dependent extracts at 60 min after
activation. When added to the extract that had been treated
with 75 nM N-cyclin B2, in which Cdc2 inhibitory phos-
phorylation did not occur, N-cyclin B2 generated Cdc2
activity in a dose-dependent manner within 30 min after
the addition (Fig. 3B, M). In contrast, in the extract treated
with 63 nM N-cyclin B2, in which Cdc2 was tyrosine
FIG. 4. The dependence of cyclin B degradation on the Cdc2
activity level. (A) 35S-Labeled cyclin B2 synthesized with egg
extracts were incubated for 10 min with N-cyclin B-dependent
extracts at 30 min after activation, and processed for autoradiogra-
phy. (B) The extent of degradation of 35S-labeled cyclin B2 in a
10-min incubation with N-cyclin B-dependent extract is plotted
as a function of the Cdc2 activity level. Results from two indepen-
dent experiments were combined. Results from the same experi-
ments are represented by the same symbols. Cdc2 activity levels of
extracts are represented as relative values to that in the same batch
of extract devoid of M phase cyclins.
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phosphorylated, added N-cyclin B2 did not generate Cdc2
activity in 30 min after the addition (Fig. 3B, S). Thus, in egg
extracts, Cdc2 inhibitory phosphorylation, which is acti-
vated by Cdc2 inactivation at M phase exit, restrains the
following Cdc2 activation caused by cyclin B accumulation.
Dependence of Cyclin B Degradation on the Cdc2
Activity Level
In egg extracts that reproduce the progression of mitotic
cycles, cyclin B proteins start accumulating as soon as Cdc2
is inactivated at the end of M phase (Murray and Kirschner,
1989; Iwabuchi et al., 2000). This suggests that the cessa-
tion of cyclin B degradation at M phase exit is dependent on
Cdc2 inactivation. We quantitatively examined the activity
for cyclin B degradation in cyclin B-dependent extracts,
using 35S-labeled cyclin B as a substrate. The Xenopus
cyclin B2 protein synthesized in egg extracts in the presence
of 35S-methionine was added to cyclin B-dependent ex-
tracts and examined for its degradation during a 10-min
incubation period (Fig. 4A). The rate of degradation is
plotted against the Cdc2 activity level in extracts to which
labeled cyclin B2 was added (Fig. 4B). As shown in the
figure, labeled cyclin B was mostly degraded in extracts
with higher levels of Cdc2 activity, but was not in those
with the subthreshold levels of Cdc2 activity. Thus, like
Cdc2 inhibitory phosphorylation, cyclin B degradation op-
erates in an all-or-none fashion, depending on the Cdc2
activity level. Importantly, the critical level of Cdc2 activ-
ity for cyclin B degradation to be turned off (3; Fig. 4B) is
lower than that for Cdc2 inhibitory phosphorylation to be
turned on (4; Fig. 1B). This differential regulation of cyclin
B degradation and Cdc2 inhibitory phosphorylation by Cdc2
activity was reproducibly confirmed in three independent
experiments (data not shown). These results indicate that
the cessation of cyclin B degradation at M phase exit is
necessarily accompanied by the activation of Cdc2 inhibi-
tory phosphorylation in egg extracts.
DISCUSSION
In this study, we used unfertilized Xenopus eggs to
prepare cyclin B-dependent extracts, in which the extent
of Cdc2 inactivation at M phase exit is quantitatively
controlled. The present results showed that, in cyclin
B-dependent extracts, the cell cycle phase was determined
exclusively as M phase or S phase, according to the Cdc2
activity level, and the G1 phase-like state, i.e., nuclear
formation without accompanying DNA replication, was
FIG. 5. The regulation of the early embryonic cell cycle by the Cdc2 activity level. (A) The dependence on the Cdc2 activity level of chromatin
morphology, MCM binding, DNA replication, M phase cyclin degradation, and Cdc2 inhibitory phosphorylation at M phase exit in egg extracts.
Solid and open bars represent their on and off states, respectively. (B) The levels of Cdc2 activity and cyclin B protein as a function of time during
the period from an M phase to the next one in the early embryonic cell cycle. The bars above the graph indicate the on and off states of cyclin
B degradation and Cdc2 inhibitory phosphorylation, and the cell-cycle phase is shown below the graph. See text for details.
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never observed (Fig. 2). In addition, we have confirmed that,
in activated CSF extracts, the incorporation of labeled ATP
by nuclear chromatin became detectable concomitantly
with nuclear formation, and so did it in cyclin
B-dependent extracts (K.O., unpublished results). These
results indicate the absence of G1 phase in activated CSF
extracts, suggesting strongly that in the first cycle of
fertilized Xenopus eggs, the cell cycle progresses from M
phase to S phase without intervening G1 phase, as it does in
the following early embryonic cycles.
Using cyclin B-dependent extracts, we demonstrated
that XMcm3 could bind to condensed chromatin in the M
phase-like state, owing to the fact that XMcm3 binding to
chromatin occurred at higher levels of Cdc2 activity than
nuclear formation accompanying DNA replication (Fig. 2).
This result is consistent with the observation that XMcm3
is loaded onto chromatin within 10 min after metaphase–
anaphase transition, prior to nuclear formation (Jares and
Blow, 2000). The temporal order that MCM binding pre-
cedes nuclear formation during the M-S transition period
can be essential for successful DNA replication in S phase,
since it has been shown that the entry of XMcm3 into
nuclei is prevented by the nuclear envelope (Kubota et al.,
1997) although contradictory results have also been re-
ported (Madine et al., 1995). The regulation of MCM
binding to chromatin by Cdc2 activity has been suggested
by proposing that the setting of replication origin on chro-
matin is directly caused by loss of Cdc2 activity (Noton and
Diffley, 2000). In addition, it has been demonstrated re-
cently that geminin inhibits Cdt1, which recruits the MCM
complex onto DNA, and therefore, APC-dependent degra-
dation of geminin at M phase exit is a necessary prerequi-
site for MCM binding (McGarry and Kirschner, 1998; Tada
et al., 2001; Wohlschlegel et al., 2001). The dependence of
MCM binding on the Cdc2 activity level suggests that
degradation of geminin and/or Cdt1 activity may be regu-
lated depending on the Cdc2 activity level during the M-S
transition period.
In a previous study, we showed that Cdc2 inhibitory
phosphorylation can be regulated by the Cdc2 activity level
(Iwabuchi et al., 2000). The present results demonstrated
that cyclin B degradation was also regulated in an all-or-
none fashion depending on the Cdc2 activity level. Impor-
tantly, the critical level of Cdc2 activity for Cdc2 inhibitory
phosphorylation to be turned on was significantly higher
than that for cyclin B degradation to be turned off (Fig. 5A);
according to the rate of decrease in the cyclin B amount in
activated CSF extracts, it is estimated that the turning-off
of cyclin B degradation lags for 2 min behind the turning-on
of Cdc2 inhibitory phosphorylation during the M-S transi-
tion period (K.O., unpublished result). Because of this
condition, when cyclin B degradation ceases at the end of M
phase, Cdc2 inhibitory phosphorylation has been activated.
Once turned on, Cdc2 inhibitory phosphorylation could
restrain the subsequent Cdc2 activation caused by cyclin B
accumulation (Fig. 3B). Thus, in the presence of constitu-
tive synthesis of cyclin B, the differential regulation of Cdc2
inhibitory phosphorylation and cyclin B degradation en-
sures that M phase exit is followed by the Cdc2 inactivation
period, during which progression through S phase is com-
pleted. In Xenopus embryos, Cdc2 is actually tyrosine-
phosphorylated during S phase in early embryonic cell
cycles (Kim et al., 1998; Iwabuchi et al., 2000, see also
Okano-Uchida et al., 1998).
In the early embryonic cell cycle, the fluctuation of Cdc2
activity levels during the period from a metaphase to the
next comprises three phases: a rapid decrease, a slow
increase, and a rapid increase (Fig. 5B). The turning from the
first phase to the second one is plausibly explained by the
aforementioned finding. The transition from the second
phase to the third one is induced by the dephosphorylation
of Thr14 and Tyr15 on Cdc2, which is catalyzed by Cdc25
(Coleman and Dunphy, 1994; Morgan, 1995), and the result-
ing rapid activation of Cdc2 turns on cyclin B degradation,
thereby inducing the turning from the third phase to the
first one. The delay between Cdc2 activation and the
commencement of cyclin B degradation in M phase can be
explained by transient inhibition of the APC by an early
mitotic inhibitor, Emil (Reimann et al., 2001). Thus, under
the constitutive synthesis of cyclin B, the Cdc2-dependent
regulation of Cdc2 inhibitory phosphorylation and cyclin B
degradation can produce the apparently complicated pat-
tern of fluctuation of Cdc2 activity by which the early
embryonic alteration of M phase and S phase is regulated.
cyclin B-dependent extract used in this study provides a
useful tool to examine the quantitative dependence on
Cdc2 activity of cellular phenomena which could be crucial
for successful M-S transition in the early embryonic cell
cycle. In addition, since Cdc2 activity levels constantly
decrease along the lapse of time during M phase exit,
sequential changes of Cdc2-dependent phenomena along
the decrease of Cdc2 activity levels in cyclin B-dependent
extracts are thought to mimic those along the time during
M phase exit. Thus, cyclin B-dependent extract is also
helpful to elucidate the temporal order of and causal rela-
tionship between Cdc2-dependent phenomena taking place
during the very short M-S transition period in the early
embryonic cell cycle.
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